Beil, Michael
van Heerden, P. Vernon
de Lange, Dylan W.
Szczeklik, Wojciech
Leaver, Susannah
Guidet, Bertrand
Flaatten, Hans
Jung, Christian
Sviri, Sigal
Joskowicz, Leo
Clinical trials referenced in this document:
Documents that mention this clinical trial
Contribution of information about acute and geriatric characteristics to decisions about life-sustaining treatment for old patients in intensive care
https://doi.org/10.1186/s12911-022-02094-z
Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort study
https://doi.org/10.1186/s13054-021-03632-3
Provision of critical care for the elderly in Europe: a retrospective comparison of national healthcare frameworks in intensive care units
https://doi.org/10.1136/bmjopen-2020-046909
Documents that mention this clinical trial
Contribution of information about acute and geriatric characteristics to decisions about life-sustaining treatment for old patients in intensive care
https://doi.org/10.1186/s12911-022-02094-z
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years
https://doi.org/10.1186/s13613-024-01246-w
Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort study
https://doi.org/10.1186/s13054-021-03632-3
Provision of critical care for the elderly in Europe: a retrospective comparison of national healthcare frameworks in intensive care units
https://doi.org/10.1136/bmjopen-2020-046909
The role of clinical phenotypes in decisions to limit life-sustaining treatment for very old patients in the ICU
https://doi.org/10.1186/s13613-023-01136-7
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 30 March 2021
Accepted: 23 December 2022
First Online: 6 January 2023
Declarations
:
: Ethics approval for the observational studies was granted by the National Regional Board in Helse Sør-Øst in Norway (reference numbers for VIP1: 2016/806/REK and VIP2: 2018/87/REK). That included permission to access data. Then, each participating country in VIP1 and VIP2 had a national coordinator responsible for national or regional ethical and regulatory study approval [CitationRef removed, CitationRef removed]. This included ethics committees which waived the need for informed consent, such as in Poland (Jagiellonian University Krakow, reference number: 122.6120.270.2016), Austria (Medical University Innsbruck, reference number: 1225/2018) and Norway (see above). All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: All authors declare that they have no competing interests.